Oncology Videos | pharmaphorum

Video

Oncology

A cancer treatment modality that prioritises QoL, with Ben Z...

Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.

Oncology

Engineering “smarter” cells, with Tim Lu

Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone

Oncology

Astellas’ banner year and focused R&D strategy, with Adam Pe...

At JPM2026, Astellas' chief strategy officer Adam Pearson walked pharmaphorum through the company’s four-pillared R&D strategy.

Oncology

Unlocking the future of epigenetics, with Carlos Buesa

Carlos Buesa, CEO of Oryzon Genomics, discusses exploring how epigenetics is reshaping the landscape of oncology and CNS therapies.

Oncology

Interview at ESMO 2025 with Dr Ebrahim Delpassand

ESMO25: On radiopharmaceutical possibilities in oncology, wi...

At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix.

Oncology

Interview at ESMO 2025 with Michael Lahn, iOnctura

ESMO25: On allosteric modulation in oncology, with Michael L...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura.

A cancer treatment modality that prioritises QoL, with Ben Z...

Engineering “smarter” cells, with Tim Lu

Astellas’ banner year and focused R&D strategy, with Adam Pe...

Unlocking the future of epigenetics, with Carlos Buesa

ESMO25: On radiopharmaceutical possibilities in oncology, wi...

ESMO25: On allosteric modulation in oncology, with Michael L...

Lilly unveils employer scheme for weight-loss drug Zepbound

Using AI-driven synthetic personas to take your insights fur...

Video

Editor's Picks